These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1444664)

  • 41. Comparison of amoxicillin and clavulanic acid (augmentin) for the treatment of nonbullous impetigo.
    Dagan R; Bar-David Y
    Am J Dis Child; 1989 Aug; 143(8):916-8. PubMed ID: 2667333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of augmentin with co-trimoxazole for treatment of uncomplicated urinary tract infections.
    Bailey RR; Bishop V; Peddie B; Chambers PF; Davies PR; Crofts HG
    N Z Med J; 1983 Nov; 96(744):970-2. PubMed ID: 6605501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatocellular-cholestatic liver injury due to amoxycillin-clavulanic acid combination.
    Habior A; Walewska-Zielecka B; Butruk E
    Clin Investig; 1994 Aug; 72(8):616-8. PubMed ID: 7819719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Twice-daily antibiotics in the treatment of acute otitis media: trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate.
    Feldman W; Sutcliffe T; Dulberg C
    CMAJ; 1990 Jan; 142(2):115-8. PubMed ID: 2403833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Results of a multicenter study of an amoxicillin-clavulanic acid combination in sinusitis in children and adults].
    Le Clech G; Bourdinière J
    Ann Otolaryngol Chir Cervicofac; 1987; 104(2):147-50. PubMed ID: 3300504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of skin and skin structure infections: a comparative study of Augmentin and cefaclor.
    Parish LC; Aten EM
    Cutis; 1984 Dec; 34(6):567-70. PubMed ID: 6394217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Augmentin bioavailability following cimetidine, aluminum hydroxide and milk.
    Staniforth DH; Clarke HL; Horton R; Jackson D; Lau D
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):154-7. PubMed ID: 3838971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bacterial infection in the newborn by maternal-fetal contamination: oral antibiotic treatment of the colonized newborn. Prospective study at a maternity unit].
    Blond MH; Gold F; Marchand S; Pierre F; Congard B; Soutoul JH; Laugier J
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(8):1057-60. PubMed ID: 2081867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Augmentin in the combined therapy of puerperal diseases].
    Emel'ianov AI; Ankirskaia AS
    Antibiot Khimioter; 1992 Sep; 37(9):27-8. PubMed ID: 1444665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pediatric suspensions of amoxicillin and clavulanic acid in the treatment of bacterial infections of otorhinolaryngologic importance and the upper respiratory tract].
    Amendola F; Natuzzi M; De Mattia D; Schettini F
    Minerva Pediatr; 1989 Feb; 41(2):97-103. PubMed ID: 2786988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [How I do it. Perioperative preventive use of antibiotics in tumor surgery of the head and neck].
    Luckhaupt H
    Laryngorhinootologie; 1989 Oct; 68(10):582. PubMed ID: 2818787
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacokinetics of a syrup formulation of amoxycillin-potassium clavulanate in children.
    Schaad UB; Casey PA; Ravenscroft AT
    J Antimicrob Chemother; 1986 Mar; 17(3):341-5. PubMed ID: 3700293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy of amoxycillin/clavulanate (Augmentin) in the treatment of severe staphylococcal infections.
    Moreillon P
    J Chemother; 1994 Apr; 6 Suppl 2():51-7. PubMed ID: 7799055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical pharmacokinetics of amoxicillin and clavulanate.
    Reed MD
    Pediatr Infect Dis J; 1996 Oct; 15(10):949-54. PubMed ID: 8895939
    [No Abstract]   [Full Text] [Related]  

  • 55. Severe neutropenia in prolonged treatment with orally administered Augmentin (amoxicillin/clavulanic acid).
    Desgrandchamps D; Schnyder C
    Infection; 1987; 15(4):260-1. PubMed ID: 3666968
    [No Abstract]   [Full Text] [Related]  

  • 56. Augmentin treatment of bacterial infections in hospitalised patients.
    Ellis-Pegler RB; Lang SD; Downey DJ; Anderson MP
    N Z Med J; 1982 Aug; 95(713):542-5. PubMed ID: 6752781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in mice.
    Aronoff SC; Jacobs MR; Labrozzi PH; Yamabe S
    J Antimicrob Chemother; 1986 Aug; 18(2):271-6. PubMed ID: 3019987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparative study of the effect of oral treatment with augmentin, amoxycillin and bacampicillin on the faecal flora in mice.
    Hofstra W; Welling GW; Van der Waaij D
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Jul; 269(1):78-85. PubMed ID: 3051802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Augmentin--current and prospective therapeutic indications].
    Mihălţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):203-10. PubMed ID: 2855664
    [No Abstract]   [Full Text] [Related]  

  • 60. Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.
    Leigh DA; Bradnock K; Marriner JM
    J Antimicrob Chemother; 1981 Mar; 7(3):229-36. PubMed ID: 6974165
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.